⌘K

Login Start Free

Home/Filings/4/0001235802-24-000046

4//SEC Filing

Lewis Tanya 4

Accession 0001235802-24-000046

CIK 0001401040other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:14 PM ET

Size

6.0 KB

Accession

0001235802-24-000046

Insider Transaction Report

Form 4

Period: 2024-06-01

DiaMedica Therapeutics Inc.DMAC

Director

Transactions

Award
Stock Option (right to buy)
2024-06-01+28,472→ 28,472 total
Exercise: $2.90Exp: 2034-05-31→ Common Shares (28,472 underlying)

Holdings

Voting Common Shares, no par value per share
0

Footnotes (1)

[F1]Vests in four nearly equal quarterly installments over one year.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1

filerCIK 0001451038

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:14 PM ET
Size: 6.0 KB

View on SEC.gov